Mary Jane Berlin 2025 proved once again why it’s Europe’s premier cannabis networking event – and our team, including our CEO, was at the heart of the action. As a research-driven company specializing in cannabis-derived active compounds and cannabinoids, events like these are crucial for building the partnerships that drive our work forward.
Why Networking Fuels Our Research
In cannabinoid science, collaboration is everything. At the exclusive B2B lounge, we connected with:
- Cultivators & processors working with novel cannabis strains
- Biotech innovators developing cutting-edge extraction methods
- Medical researchers exploring new therapeutic applications
At Mary Jane Berlin 2025, we strengthened relationships that directly benefit our cannabinoid research in three critical ways: First, these connections provide us with valuable strain data that forms the foundation of our research into cannabis-derived active compounds. By collaborating with expert cultivators and processors, we gain access to detailed chemovar profiles that help us identify promising candidates for therapeutic development. Second, networking at this level exposes us to new approaches to cannabinoid applications that we might not discover in isolation. Through conversations with biotech innovators and medical researchers, we encounter fresh perspectives on extraction methods, formulation techniques, and potential clinical uses that can inspire breakthroughs in our own work. Perhaps most importantly, these industry interactions create opportunities to develop strategic partners for both clinical and commercial development. Whether it’s finding the right cultivation partner for a specific research project or connecting with investors who understand the science behind cannabinoid therapies, these relationships accelerate our ability to translate research into real-world solutions.
The B2B Lounge: A Hub for Scientific Exchange
Our most valuable moments came from deep-dive discussions about:
- Emerging minor cannabinoids with therapeutic potential
- Novel delivery systems for cannabinoid formulations
- Regulatory challenges in cannabis research
One game-changing conversation could lead to the next breakthrough in our active compound research.
What’s Growing From These Connections?
While we can’t share details yet, these interactions are already developing into:
- Research partnerships with cultivation experts
- Data-sharing agreements to accelerate our studies
- Innovation collaborations on new cannabinoid applications
Why This Matters for Cannabinoid Science
The cannabis industry moves fast. By maintaining strong ties with:
- Growers developing new chemovars
- Labs advancing analytical methods
- Clinicians studying real-world effects
We ensure our research stays grounded in industry needs while pushing scientific boundaries.
Stay tuned becazse these connections will bear fruit in our coming announcements!